Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer

Bibliography

• Lockshin RA, Zakeri Z. Cell death in health and disease. J Cell Mol Med 2007;11:1214-24
   PubMed Web of Science ®Google Scholar
• Fulda S, Debatin KM. 5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 2006;25:5125-33
   PubMed Web of Science ®Google Scholar
• Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008;9:231-41
   PubMed Web of Science ®Google Scholar
• Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 2008;19:325-31
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Galluzzi L, Vanden Berghe T, Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010;11:700-14
   PubMed Web of Science ®Google Scholar
• Fulda S. Autophagy and cell death. Autophagy 2012;8:1250-1
   PubMed Web of Science ®Google Scholar
• Eisenberg-Lerner A, Bialik S, Simon HU, Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009;16:966-75
   PubMed Web of Science ®Google Scholar
• Fulda S. Tumor resistance to apoptosis. Int J Cancer 2009;124:511-15
   PubMed Web of Science ®Google Scholar
• Shirley S, Micheau O. Targeting c-FLIP in cancer. Cancer Lett 2010; [Epub ahead of print]
   Google Scholar
• Micheau O, Thome M, Schneider P, The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 2002;277:45162-71
   PubMedGoogle Scholar
• Tenev T, Bianchi K, Darding M, The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011;43:432-48
   PubMed Web of Science ®Google Scholar
• Feoktistova M, Geserick P, Kellert B, cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011;43:449-63
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Vitale I, Abrams JM, Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012;19:107-20
   PubMed Web of Science ®Google Scholar
• Kaiser WJ, Upton JW, Long AB, RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011;471:368-72
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhou X, McQuade T, Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011;471:373-6
   Google Scholar
• Oberst A, Dillon CP, Weinlich R, Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011;471:363-7
   PubMed Web of Science ®Google Scholar
• Lee JS, Li Q, Lee JY, FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 2009;11:1355-62
   PubMed Web of Science ®Google Scholar
• Park D, Shim E, Kim Y, C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression. Mol Cells 2008;25:184-95
   Google Scholar
• Stagni V, di Bari MG, Cursi S, ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells. Blood 2008;111:829-37
   PubMed Web of Science ®Google Scholar
• Chaudhary PM, Eby MT, Jasmin A, Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 2000;19:4451-60
   PubMed Web of Science ®Google Scholar
• Kataoka T, Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol Cell Biol 2004;24:2627-36
   PubMedGoogle Scholar
• Kataoka T, Budd RC, Holler N, The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 2000;10:640-8
   PubMed Web of Science ®Google Scholar
• Golks A, Brenner D, Krammer PH, The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J Exp Med 2006;203:1295-305
   PubMedGoogle Scholar
• Skurk C, Maatz H, Kim HS, The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem 2004;279:1513-25
   PubMed Web of Science ®Google Scholar
• Salon C, Eymin B, Micheau O, E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ 2006;13:260-72
   Google Scholar
• Haga S, Terui K, Zhang HQ, Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003;112:989-98
   PubMed Web of Science ®Google Scholar
• Ricci MS, Jin Z, Dews M, Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol Cell Biol 2004;24:8541-55
   PubMed Web of Science ®Google Scholar
• Micheau O, Lens S, Gaide O, NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001;21:5299-305
   PubMed Web of Science ®Google Scholar
• Bartke T, Siegmund D, Peters N, p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene 2001;20:571-80
   PubMedGoogle Scholar
• Ueffing N, Schuster M, Keil E, Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells. Blood 2008;112:690-8
   Google Scholar
• Li W, Zhang X, Olumi AF. MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L). Cancer Res 2007;67:2247-55
   PubMed Web of Science ®Google Scholar
• Scuto A, Kirschbaum M, Kowolik C, The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells. Blood 2008;111:5093-100
   PubMed Web of Science ®Google Scholar
• Martinez-Balbas MA, Bauer UM, Nielsen SJ, Regulation of E2F1 activity by acetylation. Embo J 2000;19:662-71
   PubMed Web of Science ®Google Scholar
• Yuan ZL, Guan YJ, Chatterjee D, Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005;307:269-73
   PubMed Web of Science ®Google Scholar
• Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep 2003;4:484-90
   PubMed Web of Science ®Google Scholar
• Patel JH, Du Y, Ard PG, The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 2004;24:10826-34
   PubMedGoogle Scholar
• Pathil A, Armeanu S, Venturelli S, HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. Hepatology 2006;43:425-34
   PubMed Web of Science ®Google Scholar
• Chen F, Zhu HH, Zhou LF, Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells. Oncol Rep 2010;23:1457-62
   PubMed Web of Science ®Google Scholar
• Chang L, Kamata H, Solinas G, The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006;124:601-13
   PubMed Web of Science ®Google Scholar
• Kundu M, Pathak SK, Kumawat K, A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis. Nat Immunol 2009;10:918-26
   PubMed Web of Science ®Google Scholar
• Haag C, Stadel D, Zhou S, Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells. Gut 2011;60:225-37
   PubMed Web of Science ®Google Scholar
• Fulda S, Meyer E, Debatin KM. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000;60:3947-56
   PubMed Web of Science ®Google Scholar
• Panner A, James CD, Berger MS, mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol 2005;25:8809-23
   PubMed Web of Science ®Google Scholar
• Guo F, Sigua C, Tao J, Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Cancer Res 2004;64:2580-9
   PubMed Web of Science ®Google Scholar
• Aron JL, Parthun MR, Marcucci G, Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood 2003;102:652-8
   PubMed Web of Science ®Google Scholar
• Watanabe K, Okamoto K, Yonehara S. Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP. Cell Death Differ 2005;12:10-18
   PubMed Web of Science ®Google Scholar
• Hernandez A, Thomas R, Smith F, Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 2001;130:265-72
   PubMedGoogle Scholar
• Schuchmann M, Schulze-Bergkamen H, Fleischer B, Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy. Oncol Rep 2006;15:227-30
   PubMed Web of Science ®Google Scholar
• Frew AJ, Lindemann RK, Martin BP, Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist. Proc Natl Acad Sci USA 2008;105:11317-22
   PubMed Web of Science ®Google Scholar
• Bangert A, Cristofanon S, Eckhardt I, Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP. Oncogene 2012; [Epub ahead of print]
   Google Scholar
• Yerbes R, Lopez-Rivas A. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL. Invest New Drugs 2012;30:541-7
   Google Scholar
• Kerr E, Holohan C, McLaughlin KM, Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis. Cell Death Differ 2012;19:1317-27
   Google Scholar
• Liu X, Yue P, Chen S, The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Cancer Res 2007;67:4981-8
   PubMed Web of Science ®Google Scholar
• Seki N, Toh U, Sayers TJ, Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways. Mol Cancer Ther 2010;9:1842-51
   PubMed Web of Science ®Google Scholar
• Zhao X, Qiu W, Kung J, Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Leuk Res 2008;32:275-85
   PubMed Web of Science ®Google Scholar
• Conticello C, Adamo L, Giuffrida R, Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death. J Clin Endocrinol Metab 2007;92:1938-42
   PubMedGoogle Scholar
• Koschny R, Holland H, Sykora J, Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Clin Cancer Res 2007;13:3403-12
   PubMed Web of Science ®Google Scholar
• Sayers TJ, Brooks AD, Koh CY, The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood 2003;102:303-10
   PubMed Web of Science ®Google Scholar
• Unterkircher T, Cristofanon S, Vellanki SH, Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis. Clin Cancer Res 2011;17:4019-30
   PubMed Web of Science ®Google Scholar
• Zou W, Liu X, Yue P, PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells. Cancer Biol Ther 2007;6:99-106
   PubMed Web of Science ®Google Scholar
• Kim YH, Jung EM, Lee TJ, Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med 2008;44:1055-68
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Yoshikawa H, Shiiki K, Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression. Int J Cancer 2000;88:986-91
   PubMed Web of Science ®Google Scholar
• Abedini MR, Muller EJ, Brun J, Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells. Cancer Res 2008;68:4511-17
   PubMed Web of Science ®Google Scholar